Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides

Author： Barg J.   Fride E.   Hanus L.   Levy R.   Matus-Leibovitch N.   Heldman E.   Bayewitch M.   Mechoulam R.   Vogel Z.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.287, Iss.2, 1995-12, pp. : 145-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: two mutually opposing effects

By Accomazzo M.R.   Cattaneo S.   Nicosia S.   Rovati G.E.  

European Journal of Pharmacology, Vol. 454, Iss. 2, 2002-11 ,pp. : 107-114

Elsevier

Access to resources Recommend Favorite

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 3, 2011-01 ,pp. : 204-214

Bentham Science Publishers

Access to resources Recommend Favorite

Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors

By Ezeamuzie C.I.  

European Journal of Pharmacology, Vol. 417, Iss. 1, 2001-04 ,pp. : 11-18

Elsevier

Access to resources Recommend Favorite

G protein regulation of adenylate cyclase

By Simonds W.F.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 2, 1999-02 ,pp. : 66-73

Elsevier

Access to resources Recommend Favorite

Electrical and mechanical effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in the rat colon involve different mechanisms

By Pluja L.   Fernandez E.   Jimenez M.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite